Search Results - "Naipal, Kishan A T"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Tumor slice culture system to assess drug response of primary breast cancer by Naipal, Kishan A T, Verkaik, Nicole S, Sánchez, Humberto, van Deurzen, Carolien H M, den Bakker, Michael A, Hoeijmakers, Jan H J, Kanaar, Roland, Vreeswijk, Maaike P G, Jager, Agnes, van Gent, Dik C

    Published in BMC cancer (09-02-2016)
    “…The high incidence of breast cancer has sparked the development of novel targeted and personalized therapies. Personalization of cancer treatment requires…”
    Get full text
    Journal Article
  2. 2

    Ex vivo assays to predict enhanced chemosensitization by hyperthermia in urothelial cancer of the bladder by van den Tempel, Nathalie, Naipal, Kishan A T, Raams, Anja, van Gent, Dik C, Franckena, Martine, Boormans, Joost L, Kanaar, Roland

    Published in PloS one (14-12-2018)
    “…Bladder cancer (urothelial carcinoma) is a common malignancy characterized by high recurrence rates and intense clinical follow-up, indicating the necessity…”
    Get full text
    Journal Article
  3. 3

    Attenuated XPC expression is not associated with impaired DNA repair in bladder cancer by Naipal, Kishan A T, Raams, Anja, Bruens, Serena T, Brandsma, Inger, Verkaik, Nicole S, Jaspers, Nicolaas G J, Hoeijmakers, Jan H J, van Leenders, Geert J L H, Pothof, Joris, Kanaar, Roland, Boormans, Joost, van Gent, Dik C

    Published in PloS one (30-04-2015)
    “…Bladder cancer has a high incidence with significant morbidity and mortality. Attenuated expression of the DNA damage response protein Xeroderma Pigmentosum…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Oral antibiotics lower mycophenolate mofetil drug exposure, possibly by interfering with the enterohepatic recirculation: A case series by Simoons, Mirjam, Naipal, Kishan A. T., Jong, Huib, Hoed, Caroline M., Winter, Brenda C. M., Mulder, Midas B.

    Published in Pharmacology research & perspectives (01-06-2023)
    “…Mycophenolate mofetil has an important role as immunosuppressive agent in solid organ transplant recipients. Exposure to the active mycophenolic acid (MPA) can…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Ex vivo tumor culture systems for functional drug testing and therapy response prediction by Meijer, Titia G, Naipal, Kishan At, Jager, Agnes, van Gent, Dik C

    Published in Future science OA (01-05-2017)
    “…Optimal patient stratification is of utmost importance in the era of personalized medicine. Prediction of individual treatment responses by functional assays…”
    Get full text
    Journal Article
  8. 8

    Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma by Blank, Christian U., Lucas, Minke W., Scolyer, Richard A., van de Wiel, Bart A., Menzies, Alexander M., Lopez-Yurda, Marta, Hoeijmakers, Lotte L., Saw, Robyn P.M., Lijnsvelt, Judith M., Maher, Nigel G., Pulleman, Saskia M., Gonzalez, Maria, Torres Acosta, Alejandro, van Houdt, Winan J., Lo, Serigne N., Kuijpers, Anke M.J., Spillane, Andrew, Klop, W. Martin C., Pennington, Thomas E., Zuur, Charlotte L., Shannon, Kerwin F., Seinstra, Beatrijs A., Rawson, Robert V., Haanen, John B.A.G., Ch’ng, Sydney, Naipal, Kishan A.T., Stretch, Jonathan, van Thienen, Johannes V., Rtshiladze, Michael A., Wilgenhof, Sofie, Kapoor, Rony, Meerveld-Eggink, Aafke, Grijpink-Ongering, Lindsay G., van Akkooi, Alexander C.J., Reijers, Irene L.M., Gyorki, David E., Grünhagen, Dirk J., Speetjens, Frank M., Vliek, Sonja B., Placzke, Joanna, Spain, Lavinia, Stassen, Robert C., Amini-Adle, Mona, Lebbé, Céleste, Faries, Mark B., Robert, Caroline, Ascierto, Paolo A., van Rijn, Rozemarijn, van den Berkmortel, Franchette W.P.J., Piersma, Djura, van der Westhuizen, Andre, Vreugdenhil, Gerard, Aarts, Maureen J.B., Stevense-den Boer, Marion A.M., Atkinson, Victoria, Khattak, Muhammad, Andrews, Miles C., van den Eertwegh, Alfons J.M., Boers-Sonderen, Marye J., Hospers, Geke A.P., Carlino, Matteo S., de Groot, Jan-Willem B., Kapiteijn, Ellen, Suijkerbuijk, Karijn P.M., Rutkowski, Piotr, Sandhu, Shahneen, van der Veldt, Astrid A.M., Long, Georgina V.

    Published in The New England journal of medicine (07-11-2024)
    “…Among patients who received two 3-week cycles of neoadjuvant ipilimumab and nivolumab, the 12-month event-free survival was 83.7%, as compared with 57.2% among…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Attenuated XPC Expression Is Not Associated with Impaired DNA Repair in Bladder Cancer: e0126029 by Naipal, Kishan AT, Raams, Anja, Bruens, Serena T, Brandsma, Inger, Verkaik, Nicole S, Jaspers, Nicolaas GJ, Hoeijmakers, Jan HJ, Leenders, L Hvan, Pothof, Joris, Kanaar, Roland

    Published in PloS one (01-04-2015)
    “…Bladder cancer has a high incidence with significant morbidity and mortality. Attenuated expression of the DNA damage response protein Xeroderma Pigmentosum…”
    Get full text
    Journal Article